FDA Inspection 1219616 — BioStem Life Sciences

BioStem Life Sciences — FEI 3013239405

The FDA completed an inspection of BioStem Life Sciences on Sep 15, 2023 in Pompano Beach, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 15, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pompano Beach, FL (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
176721 CFR 211.137(a)Expiration date lacking
188321 CFR 211.165(a)Testing and release for distribution

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.